Grants Ferry - UMMC
Return to Locations Search
Address:
1010 Lakeland Place
Flowood, MS 39232
Contact Us:
(601) 815-0600
Parking:
Available at the clinic
Our Care Specialties at this location:
- Alzheimer's and Dementia
- Audiology
- Cancer
- Cardiology
- Children's Allergy/Immunology
- Children's Audiology
- Children's Cardiology
- Children's Dermatology
- Children's Ear, Nose and Throat
- Children's Endocrinology
- Children's Gastroenterology
- Children's Hematology/Oncology
- Children's Neurology
- Children's Ophthalmology
- Children's Rheumatology
- Children's Urgent Care
- Dermatology
- Endocrinology and Diabetes
- General ENT and Nasal Allergies
- Geriatrics
- Gynecology
- Hypertension
- Internal Medicine
- Interventional Cardiology
- Med/Peds - Pediatric Hypertension
- Med/Peds General
- Occupational and Physical Therapy
- Pediatric and Adolescent Gynecology
- Radiology
- Women's Health
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Multicenter,Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Brexanolone in the Treatments of Adolescent Female Subjects with Postpartum Depression.IRB Number: 2019-0255
Published: October 25, 2019
View Locations
Clinical Trial Locations:
|
20191025125433 |
<div>This study will test the effects and safety of brexanolone in adolescent female diagnosed with postpartum depression. </div><div><br></div> depression;pediatrics;women's health 547-PPD-304 Sheila Belk kwallace2 Pediatrics Women's Health |
||||||||||||
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)IRB Number: 2019-0209
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125103217 |
This study will evaluate the safety and tolerability of MEDI8897 compared to palivizumab in preterm infants entering their first RSV season and children with chronic lung disease or congenital heart disease entering their first and second RSV season. pediatrics;women's health;lungs D5290C00005 Sandra Tyler abhatt Lungs/Breathing Pediatrics Women's Health |
||||||||||||
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal WomenIRB Number: 2020-0023
Published: April 07, 2020
View Locations
Clinical Trial Locations:
|
20200407093323 |
The purpose of this study is to determine how effective and safe the daily use of a particular medicine (Elagolix) helps postmenopausal women who have heavy menstrual bleeding due to fibroids. women's health M16-824 Sherrina Dixon sbouldin Women's Health |
||||||||||||
AtRial Cardiopathy and Antithrombotic Drugs In prevention After crytogenic stroke Cognition and Silent Infarcts (Cognition and Silent Infarcts)IRB Number: 2019-0280
Published: January 27, 2020
View Locations
Clinical Trial Locations:
|
20200127131950 |
This is an ancillary study to the ARCADIA trial. It will assess cognitive function and silent infarcts in a subset of the ARCADIA population. Patients randomized in ARCADIA will be eligible for ARCADIA-CSI if they can undergo cognitive testing and have no MRI contraindications.The purpose of the study is to determine the effect of apixaban vs. aspirin on these two additional outcomes in patients with stroke of unknown cause and atrial cardiopathy. stroke 2019-0280 LaTronseya Berry sshekhar Stroke/Traumatic Brain Injury |
||||||||||||
Autonomic Retulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction (ANTHEM-HFrEF)IRB Number: 2018-0176
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151856 |
The purpose of this study is to see if a new investigational device called the VITARIA system is safe and effective in treating heart failure.<br> heart ANTHEM-HFrEF Theresa Hickey Hutson rlong Heart Health |
||||||||||||
EMPERIAL STUDY: EMPagliflozin 10 mg compared with placebo on ExeRcise ability and heart failure symptoms, In patients with chronic HeArt FaiLure with preserved Ejection Fraction (HFpEF)IRB Number: 2019-0006
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133434 |
The purpose of this study is to learn more about heart failure with preserved ejection fraction which is a type of heart failure and means the heart is not working as well as it should. We also want to see if an experimental medication called empagliflozin helps improve heart failure symptoms and patients' quality of life. <br> heart 1245-0167 Theresa Hickey Hutson rlong Heart Health |
||||||||||||
EYP-DIP-001: A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood CataractIRB Number: 2021V0822
Published: October 04, 2022
View Locations
Clinical Trial Locations:
|
20221004214522 |
The purpose of this study is to test the safety of an investigational drug product, (DEXYCU), in children to treat eye inflammation (redness) caused by cataract surgery. cataract;dexycu (dexamethasone intraocular suspension) EYP-DIP-001 Morgan Ladner HongVan Le Eyes/Vision Pediatrics Surgery |
||||||||||||
Long-Term Outcomes after the Multisystem Inflammatory Syndrome in Children: MUSICIRB Number: 2020V0389
Published: October 22, 2021
View Locations
Clinical Trial Locations:
|
20211022104212 |
<div>This study will be an observational cohort study that will use routinely</div><div>collected clinical and cardiac (EKG, echocardiogram, CMR, exercise</div><div>testing) data to assess the association between MIS-C and cardiac</div><div>outcomes within the first year after hospital discharge.</div> heart;pediatrics;cardiology NCT04456439 Sandra Tyler dshakti Heart Health Pediatrics |
||||||||||||
MK-1242-035: A Pivotal Phase 3 Randomized, Placebo-controlled Vericiguat Outcomes Study in HFrEF (VICTOR)IRB Number: 2021V0793
Published: March 02, 2022
View Locations
Clinical Trial Locations:
|
20220302112702 |
This study is testing MK-1242 (vericiguat) in people with a certain type of heart failure. It will compare MK-1242 to placebo (inactive substance) when added to your existing heart failure treatment. You, your study doctor and the study staff won't know what study drug you are getting. MK-1242 is experimental. heart health;victor;mk-1242 MK-1242-035 Will Pierce lpapadimitriou Heart Health |
||||||||||||
Shared Decision Making for Stroke Prevention in Atrial FibrillationIRB Number: 2018-0104
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151617 |
This study is to see if a conversation tool called the "Anticoagulation Choice Conversation Tool" will help participants and their doctors with discussing treatment choices and adherence to therapy in patients with atrial fibrillation (AF) who are at risk for stroke.<br> stroke;brain;atrial fibrillation SDM4Afib Theresa Hickey Hutson tsuzuki Stroke/Traumatic Brain Injury |
||||||||||||
Strategic MAnagement to Improve CRT Using Multi-Site Pacing (SMART-MSP)IRB Number: 2018-0066
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528145708 |
We are doing this study to learn more about the safety and effectiveness of pacing features in the Boston Scientific Resonate pacemakers in patients with heart failure according to the device's approved labeling and after Food and Drug Administration approval of the device.<br> heart C1918 Theresa Hickey Hutson tsuzuki Heart Health |
||||||||||||
ToRsemide compArisoN with furoSemide FOR Management of Heart FailureIRB Number: 2018-0117
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528151645 |
We are doing this study to learn more about loop diuretic pills (water pills), and to see which one works better in people who have heart failure. <br> heart;heart health;heart failure NCT03296813 Connie Watson mehall Heart Health |